HCW BIOLOGICS INC. - COMMON STOCK
0.3666
13-February-25 12:10:20
15 minutes delayed
Stocks
-0.0335
-8.37%
Today's range
0.3600 - 0.3865
ISIN
N/A
Source
NASDAQ
-
28 Mar 2023 16:25:00 By Nasdaq GlobeNewswire
-
HCW Biologics Enters CRADA with National Cancer Institute
08 Dec 2022 07:56:03 By Nasdaq GlobeNewswire
-
07 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights
07 Nov 2022 16:45:00 By Nasdaq GlobeNewswire
-
HCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights
12 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
U.S. Patent Issued to HCW Biologics for Foundational Platform Technology
03 Aug 2022 07:15:00 By Nasdaq GlobeNewswire
-
23 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
13 May 2022 07:15:00 By Nasdaq GlobeNewswire
-
19 Apr 2022 07:33:00 By Nasdaq GlobeNewswire
-
28 Mar 2022 07:00:00 By Nasdaq GlobeNewswire
-
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
24 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
20 Jan 2022 08:00:03 By Nasdaq GlobeNewswire
-
19 Jan 2022 08:00:01 By Nasdaq GlobeNewswire
-
HCW Biologics to Participate in H.C. Wainwright BioConnect Conference January 10 – 13, 2022
06 Jan 2022 07:33:00 By Nasdaq GlobeNewswire
-
HCW Biologics’ Founder and CEO Dr. Hing C. Wong Named Weaver H. Gaines Entrepreneur of the Year
13 Dec 2021 07:31:00 By Nasdaq GlobeNewswire
-
HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights
12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
28 Oct 2021 07:00:01 By Nasdaq GlobeNewswire